Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LevelsRx vs TelePeptide

By GLP-1 ScorecardUpdated

LevelsRxFactor scores not reassessed.
Site position #201

Higher score

TelePeptideFactor scores not reassessed.
Site position #296

Lower score

Score comparison

LevelsRx has the higher recorded score — 66.6/100 to 62.3/100.

LevelsRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LevelsRx is a US direct-to-consumer telehealth offering compounded GLP-1 weight-loss medication, including compounded semaglutide (injectable and an oral liposomal liquid) starting at 150 dollars per month and compounded tirzepatide starting at 240 dollars per month, plus Sermorelin.

Before you choose

Before comparing the headline prices, the LevelsRx review and the TelePeptide review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, LevelsRx vs Tyde Wellness and Longevixx vs TelePeptide compare each of them with another graded program, and the list of alternatives to LevelsRx ranks the programs closest to LevelsRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Lttl review covers one graded close to these two, at 63.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueLevelsRx +24
68
44
Dose & formulationEven
75
75
Clinical oversightTelePeptide +11
76
87
Labs & monitoringTelePeptide +2
52
54
FulfillmentTelePeptide +8
69
77
Contract termsLevelsRx +21
41
20
LevelsRx · top barTelePeptide · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricLevelsRxTelePeptide
WeighScore66.6/10062.3/100
GradeCC
Site position#201#296
Semaglutide$150/mo (starting dose, compounded)$149/mo (monthly billing; $1,428 for 12 months; compounded injection)
Tirzepatide$240/mo (starting dose, compounded)$249/mo (monthly billing; $2,568 for 12 months; compounded injection)
CoverageCoverage not publishedCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
LevelsRx

Site position #201 · C

Factor scores not reassessed.

Strengths

  • Both injectable and oral semaglutide plus tirzepatide, with same-day virtual visits
  • Weight-loss money-back warranty if targets are not met
  • 24-7 phone and email support with unlimited online provider visits

What to consider

  • Compounding pharmacy is not named publicly
  • States served are not published on the site
  • Prices are 'starting at' figures that may rise with dose
TelePeptide

Site position #296 · C

Factor scores not reassessed.

Strengths

  • LegitScript-certified (seal ID 49966407); 503A-licensed compounding pharmacies
  • All-inclusive from about $119/mo on a 12-month plan ($1,428) — physician eval, Rx, medication and shipping
  • Publishes 1-, 3-, 6- and 12-month prices for both injections
  • 24/7 care team messaging + regular check-ins + dosage adjustments included at every tier
  • 48 states + DC coverage (excludes only AK + MS); no insurance required; cancel anytime

What to consider

  • Compounded medications are not FDA-approved; no pharmacy partner named publicly
  • Monthly billing costs more — $149/mo versus about $119/mo on the 12-month plan for semaglutide; the best rate requires annual prepay
  • Labs not included in any plan
  • Founder disclosed by first name only (Ahmed); no physician names or clinical leadership disclosed publicly
  • Tirzepatide injectable at $249/mo (monthly billing) is above the compounded market average

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard